Insect protein blocks bacterial infection

A protein that gives fleas their bounce has been used to boot out bacteria cells, with lab results demonstrating the material’s potential for preventing medical implant infection.

The collaborative study led by researchers at RMIT University is the first reported use of antibacterial coatings made from resilin-mimetic proteins to fully block bacteria from attaching to a surface.

Study lead author Professor Namita Roy Choudhury said the finding is a critical step towards their goal of creating smart surfaces that stop dangerous bacteria, especially antibiotic-resistant ones like MRSA, from growing on medical implants.

“This work shows how these coatings can be adjusted to effectively fight bacteria — not just in the short term, but possibly over a long period,” she said.

Professor Namita Roy Choudhury at RMIT University.

Bacteria are often found on implants following surgery, despite sterilisation and infection controls.

These can lead to infections requiring antibiotics, but with antibiotic resistance becoming more common, new preventative measures are needed.

“Antibiotic resistance has prompted greater interest in the area of self-sterilising materials and easy preparation of antibacterial surfaces,” Choudhury said.

“Therefore, we designed this surface to completely prevent the initial attachment of the bacteria and biofilm formation to decrease the infection rates.”

Choudhury said potential applications could include spray coatings for surgical tools, medical implants, catheters and wound dressings.

Resilin to the rescue

Resilin, a protein found in insects, is known for its remarkable elasticity – it enables fleas to jump more than a hundred times their own height in microseconds – but it’s also extremely resilient and biocompatible.

"These exceptional properties and non-toxic nature make resilin and resilin-mimetic proteins ideal for many applications requiring flexible, durable materials and coatings,” Choudhury said.

“These applications range from tissue engineering and drug delivery to flexible electronics and sports equipment, but this is the first work published on its performance as an antibacterial coating.”

The team created several forms of coating from altered forms of resilin, then tested their interactions with E.coli bacteria and human skin cells in lab conditions.

The study showed how the altered proteins in nano droplet form known as coacervates were 100% effective at repelling the bacteria, while still integrating well with healthy human cells, a critical part of medical implant success.

The antibacterial surface magnified 4,000 times under scanning electron microscope, showing the topographical feature of the coacervate resilin mimetic coating on the base scaffold substrate.

Study lead author from RMIT Dr Nisal Wanasingha said the nano droplets’ high surface area made them especially good at interacting with and repelling bacteria.

“Once they come in contact, the coating interacts with the negatively charged bacterial cell membranes through electrostatic forces, disrupting their integrity, leading to leakage of cellular contents and eventual cell death,” he said.

Wanasingha said the resilin-based coatings not only showed 100% effectiveness in stopping E.coli bacteria from attaching to the surface but also offered several advantages compared to traditional approaches.

“Unlike antibiotics, which can lead to resistance, the mechanical disruption caused by the resilin coatings may prevent bacteria from establishing resistance mechanisms,” he said.

“Meanwhile, resilin's natural origin and biocompatibility reduce the risk of adverse reactions in human tissues and, being protein-based, are more environmentally friendly than alternatives based on silver nanoparticles.”

Co-author from Australia's Nuclear Science and Technology Organisation (ANSTO), Associate Professor Jitendra Mata, said understanding surfaces and structures at the molecular level had provided unique perspectives to inform production of these new coatings.

"ANSTO is a unique place with world-class neutron facilities, such as the Spatz reflectometer and Quokka SANS instrument, both of which were crucial to this research," he said.

"We also have the National Deuteration Facility, which produced deuterated protein molecules that were essential to solving this complex science.”

Dr Nisal Wanasingha, Professor Namita Roy Choudhury, Professor Naba Dutta and Associate Professor Jitendra Mata with Quokka, the small angle neutron scattering instrument at the Australian Centre for Neutron Scattering. Credit: ANSTO.

Next steps

Study co-author Professor Naba Dutta said resilin-mimetic protein is highly responsive to stimuli and changes in its environment, making it potentially tuneable for many functions.

"These early results are very promising as a new way to help improve infection control in hospitals and other medical settings, but now more testing is needed to see how these coatings work against a wider range of harmful bacteria,” Dutta said.

“Future work includes attaching antimicrobial peptide segments during recombinant synthesis of resilin-mimics and incorporating additional antimicrobial agents to broaden the spectrum of activity.”

Transitioning from lab research to clinical use will require ensuring the formula’s stability and scalability, conducting extensive safety and efficacy trials, while developing affordable production methods for widespread distribution, he added.

The study was in collaboration with the ARC Centre of Excellence for Nanoscale BioPhotonics and the Australian Nuclear Science and Technology Organisation (ANSTO).

The team used ANSTO’s Australian Centre for Neutron Scattering facilities, and RMIT University’s Micro Nano Research Facility and Microscopy and Microanalysis Facility.

The work was funded by the Australia India Strategic Research Fund, Australian Institute of Nuclear Science and Engineering top-up Postgraduate Research Award (PGRA) and supported by the Australian Research Council.

‘Nano-structured antibiofilm coatings based on recombinant resilin’ is published in Advances in Colloid and Interface Science (DOI: 10.1016/j.cis.2025.103530)

To discuss collaboration, contact research.partnerships@rmt.edu.au

Story: Michael Quin

Health

03 June 2025

Return to RMIT News

Health

03 June 2025

Research
Engineering
STEM
Nano & Microtechnology
Science and technology

Engage

Contact RMIT News

Find an expert

Study with us

Research at RMIT

Related News

Australia-Spain research community gathers for the launch of the AuSpire postdoctoral network

The Australia-Spain Network for Innovation and Research Excellence (AuSpire) unites international researchers conducting projects grounded in the concept of planetary wellbeing.

RMIT research opens door to better IVF experience

A wearable device to make fertility treatment easier is being developed by a Melbourne startup in partnership with RMIT, the University of Melbourne and Monash IVF.

Smart bandage could heal and monitor wounds at the same time

Researchers have unlocked the possibility of creating smart wound dressings that enable real-time monitoring while also being able to deliver healing agents in one simple, scalable platform.

‘Sea creature’ minibot hoovers up oil spills

RMIT University engineers in Australia have built a remote-controlled minibot that hoovers up oil spills using an innovative filtering system inspired by sea urchins.

Acknowledgement of Country

RMIT University acknowledges the people of the Woi wurrung and Boon wurrung language groups of the eastern Kulin Nation on whose unceded lands we conduct the business of the University. RMIT University respectfully acknowledges their Ancestors and Elders, past and present. RMIT also acknowledges the Traditional Custodians and their Ancestors of the lands and waters across Australia where we conduct our business - Artwork 'Sentient' by Hollie Johnson, Gunaikurnai and Monero Ngarigo.

More information

Insect protein blocks bacterial infection